AbbVie | 4: Statement of changes in beneficial ownership of securities-Officer Buckbee Kevin K
AbbVie | 144: Notice of proposed sale of securities pursuant to Rule 144
AbbVie | 8-K: Kevin K. Buckbee Plans to Retire as AbbVie's Controller
AbbVie | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
AbbVie | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
AbbVie | 10-Q: Q3 2024 Earnings Report
AbbVie | 8-K: AbbVie Reports Third-Quarter 2024 Financial Results
AbbVie | 8-K: Guidance Including the Impact of Acquired IPR&D and Milestones Expense (Unaudited)
AbbVie | 4: Statement of changes in beneficial ownership of securities-Director Quaggin Susan E
AbbVie | 4: Statement of changes in beneficial ownership of securities-Director Alpern Robert J
AbbVie | 4: Statement of changes in beneficial ownership of securities-Officer GONZALEZ RICHARD A
AbbVie | 4: Statement of changes in beneficial ownership of securities-Director RAPP EDWARD J
AbbVie | 4: Statement of changes in beneficial ownership of securities-Officer SALEKI-GERHARDT AZITA
AbbVie | 8-K: Current report
AbbVie | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
AbbVie | 144: Notice of proposed sale of securities pursuant to Rule 144
AbbVie | 4: Statement of changes in beneficial ownership of securities-Officer GONZALEZ RICHARD A
AbbVie | 144: Notice of proposed sale of securities pursuant to Rule 144
AbbVie | 10-Q: Q2 2024 Earnings Report
AbbVie | 144: Notice of proposed sale of securities pursuant to Rule 144